Related Experiment Video
Updated: Jul 12, 2026

Chronic Thromboembolic Pulmonary Hypertension and Assessment of Right Ventricular Function in the Piglet
Published on: November 4, 2015
Correlation between cardiac biomarkers and right ventricular enlargement on chest CT in non massive pulmonary
Nicolas Vuilleumier1, Marc Righini, Arnaud Perrier
1Department of Pathology, Clinical Chemistry, Geneva University Hospital, Switzerland. nicolas.vuilleumier@hcuge.ch
Insights
Natriuretic peptides are significantly elevated in patients with pulmonary embolism (PE) and right ventricular dysfunction (RVD). These peptides correlate with RVD severity, unlike other cardiac biomarkers.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Biomarker Research
Background:
- Pulmonary embolism (PE) is associated with elevated cardiac biomarkers including troponin I, myoglobin, H-FABP, and natriuretic peptides.
- Right ventricular dysfunction (RVD) is a critical complication in PE.
Purpose of the Study:
- To investigate the correlation between cardiac biomarkers and helical computed tomography (hCT) assessed RVD in non-massive PE patients.
- To compare the diagnostic utility of natriuretic peptides versus cardiomyocyte damage markers in identifying RVD.
Main Methods:
- Prospective pilot study involving 50 patients with non-massive PE.
- Assessment of troponin I, myoglobin, H-FABP, BNP, and NT-proBNP levels.
- Correlation analysis with hCT-derived right ventricular dysfunction (RVD) and RV/LV index.
Main Results:
- Natriuretic peptides showed significantly higher prevalence and median plasma values in patients with RVD compared to those without.
- BNP and NT-proBNP levels were significantly higher in patients with RVD.
- Significant correlations were found between the RV/LV index and plasma levels of NT-proBNP and BNP.
Conclusions:
- Elevated natriuretic peptides (BNP, NT-proBNP) are significantly associated with the presence and severity of RVD in non-massive PE.
- Natriuretic peptides demonstrate greater diagnostic value for RVD in PE than cardiomyocyte damage markers.
Background:
Troponin I (cTnI), myoglobin, heart-type fatty acid binding protein (H-FABP), and natriuretic peptides (BNP, NTproBNP) were all reported to be elevated in patients with pulmonary embolism (PE).
Methods:
To assess the correlation between the aforementioned markers and helical computed tomography (hCT) right ventricular dysfunction (RVD) in non massive PE, we performed this prospective pilot study on 50 patients.
Results:
Patients with RVD had significant higher natriuretic peptides prevalence than cardiomyocytes damage-related markers (48% vs 20%, P=0.006). Significant prevalence differences were observed only for natriuretic peptides when patients with RVD and those without were compared (74% vs 33% for NT-pro BNP, P=0.005 and 65% vs 22% for BNP, P=0.003). Patients with RVD had significant higher biomarkers median plasmatic values than those without (BNP: 170 vs 36 pg/ml, P=0.0027; NT-proBNP: 1369 vs 170.7 pg/ml, P=0.0024; cTnI: 0.032 vs 0 ng/ml, P=0.0034; H-FABP: 4.32 vs 2.23 ng/ml, P=0.0032; myoglobin: 36.7 vs 28.2 ng/ml, P=0.03). Significant correlations were only obtained between RV/LV index and plasmatic natriuretic peptides (NT-proBNP: r=0.36, P=0.009; BNP r=0.28; P=0.047).
Conclusions:
Natriuretic peptides prevalence elevation and median values are significantly higher when RVD is present and significantly correlate with hCT RVD.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Imaging Studies for Cardiovascular System III: X-Ray
Definition and Purpose
An X-ray, or radiograph, is a non-invasive method that uses ionizing radiation to take images of internal structures. It is mainly used in cardiac imaging to examine the heart, lungs, and major blood vessels, aiming to identify abnormalities in the heart's size, shape, and position, such as heart failure, congenital defects, and vascular...
Imaging Studies for Cardiovascular System V: CT
Mitral Stenosis II: Clinical features and Diagnostic Tests
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Cardiac Catheterization II: Right Heart Catheterization
